Dr Amber Roby, OD - Medicare Optometrist in Oklahoma City, OK

Dr Amber Roby, OD is a medicare enrolled "Optometrist" provider in Oklahoma City, Oklahoma. Her current practice location is 211 N. Robinson, Suite 130, Oklahoma City, Oklahoma. You can reach out to her office (for appointments etc.) via phone at (405) 232-0877.

Dr Amber Roby is licensed to practice in Oklahoma (license number 2500) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1104834886.

Contact Information

Dr Amber Roby, OD
211 N. Robinson, Suite 130,
Oklahoma City, OK 73102
(405) 232-0877
(405) 232-5956



Healthcare Provider's Profile

Full NameDr Amber Roby
GenderFemale
SpecialityOptometrist
Location211 N. Robinson, Oklahoma City, Oklahoma
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1104834886
  • Provider Enumeration Date: 08/04/2006
  • Last Update Date: 07/29/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 9436158037
  • Enrollment ID: I20070205000246

Medical Identifiers

Medical identifiers for Dr Amber Roby such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1104834886NPI-NPPES
9892071OtherOKAETNA
200095670AMedicaidOK
2803373OtherOKUNITED HEALTHCARE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 2500 (Oklahoma)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Amber Roby allows following entities to bill medicare on her behalf.
Provider NameTami R Ross Pc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1114139680
PECOS PAC ID: 5799707980
Enrollment ID: O20060103000185

News Archive

Natural product darwinolide may help combat fatal MRSA infection

A serious and sometimes fatal bacterial infection, known as methicillin-resistant Staphylococcus aureus (MRSA), may soon be beatable thanks to the efforts of University of South Florida scientists who have isolated and tested an extract from a sponge found in Antarctica.

Portugal research groups awarded Gates Foundation grants

Two research groups in Portugal are to receive Grand Challenges Exploration Grants from the Bill & Melinda Gates Foundation. One of these research teams is led by Miguel Prud-ncio, at the Instituto de Medicina Molecular (IMM), and the other by Miguel Soares, at the Instituto Gulbenkian de Ci-ncia (IGC) together with Henrique Silveira, at the Instituto de Higiene e Medicina Tropical (IHMT).

New symbol announced by Horizon Health International Corp.

HORIZON HEALTH INTERNATIONAL CORP. (Formerly URANIUMCORE COMPANY, UCCO), (The Company) is pleased to announce its New Symbol: OTC-Pinksheet 'HZHI', to take effect at the open of trading, Friday, October 09, 2009.

FDA approves Halaven therapy for metastatic late-stage breast cancer

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate) to treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease.

Scottish women with metastatic carcinoma of cervix could now benefit from Avastin treatment

From today, women in Scotland with an advanced and incurable form of cervical cancer could benefit from the targeted treatment Avastin, which has been given the green light by the Scottish Medicines Consortium (SMC) for routine use on the NHS.

Read more Medical News

› Verified 7 days ago

Provider NameNjvoc Pllc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1851630313
PECOS PAC ID: 0345474383
Enrollment ID: O20131008000056

News Archive

Natural product darwinolide may help combat fatal MRSA infection

A serious and sometimes fatal bacterial infection, known as methicillin-resistant Staphylococcus aureus (MRSA), may soon be beatable thanks to the efforts of University of South Florida scientists who have isolated and tested an extract from a sponge found in Antarctica.

Portugal research groups awarded Gates Foundation grants

Two research groups in Portugal are to receive Grand Challenges Exploration Grants from the Bill & Melinda Gates Foundation. One of these research teams is led by Miguel Prud-ncio, at the Instituto de Medicina Molecular (IMM), and the other by Miguel Soares, at the Instituto Gulbenkian de Ci-ncia (IGC) together with Henrique Silveira, at the Instituto de Higiene e Medicina Tropical (IHMT).

New symbol announced by Horizon Health International Corp.

HORIZON HEALTH INTERNATIONAL CORP. (Formerly URANIUMCORE COMPANY, UCCO), (The Company) is pleased to announce its New Symbol: OTC-Pinksheet 'HZHI', to take effect at the open of trading, Friday, October 09, 2009.

FDA approves Halaven therapy for metastatic late-stage breast cancer

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate) to treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease.

Scottish women with metastatic carcinoma of cervix could now benefit from Avastin treatment

From today, women in Scotland with an advanced and incurable form of cervical cancer could benefit from the targeted treatment Avastin, which has been given the green light by the Scottish Medicines Consortium (SMC) for routine use on the NHS.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Amber Roby is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Amber Roby, OD
211 N. Robinson, Suite 130,
Oklahoma City, OK 73102

Ph: (405) 232-0877
Dr Amber Roby, OD
211 N. Robinson, Suite 130,
Oklahoma City, OK 73102

Ph: (405) 232-0877

News Archive

Natural product darwinolide may help combat fatal MRSA infection

A serious and sometimes fatal bacterial infection, known as methicillin-resistant Staphylococcus aureus (MRSA), may soon be beatable thanks to the efforts of University of South Florida scientists who have isolated and tested an extract from a sponge found in Antarctica.

Portugal research groups awarded Gates Foundation grants

Two research groups in Portugal are to receive Grand Challenges Exploration Grants from the Bill & Melinda Gates Foundation. One of these research teams is led by Miguel Prud-ncio, at the Instituto de Medicina Molecular (IMM), and the other by Miguel Soares, at the Instituto Gulbenkian de Ci-ncia (IGC) together with Henrique Silveira, at the Instituto de Higiene e Medicina Tropical (IHMT).

New symbol announced by Horizon Health International Corp.

HORIZON HEALTH INTERNATIONAL CORP. (Formerly URANIUMCORE COMPANY, UCCO), (The Company) is pleased to announce its New Symbol: OTC-Pinksheet 'HZHI', to take effect at the open of trading, Friday, October 09, 2009.

FDA approves Halaven therapy for metastatic late-stage breast cancer

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate) to treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease.

Scottish women with metastatic carcinoma of cervix could now benefit from Avastin treatment

From today, women in Scotland with an advanced and incurable form of cervical cancer could benefit from the targeted treatment Avastin, which has been given the green light by the Scottish Medicines Consortium (SMC) for routine use on the NHS.

Read more News

› Verified 7 days ago


Optometrist in Oklahoma City, OK

Pearle Vision
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 2501 W Memorial Rd, Ste 222, Oklahoma City, OK 73134
Phone: 405-775-9300    
Young Eye Clinic
Optometrist
Medicare: Medicare Enrolled
Practice Location: 12325 N Rockwell Ave, Oklahoma City, OK 73142
Phone: 405-728-3393    
Dr. Gary Robert Fox, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 10320 S Pennsylvania Ave, Suite #103, Oklahoma City, OK 73159
Phone: 405-691-3937    Fax: 405-691-0312
Forester & Pitt Vision Source
Optometrist
Medicare: Medicare Enrolled
Practice Location: 3011 Nw 63rd St, Oklahoma City, OK 73116
Phone: 405-840-2800    Fax: 405-840-8242
Vision Source
Optometrist
Medicare: Medicare Enrolled
Practice Location: 14000 Quailbrook Dr, Oklahoma City, OK 73134
Phone: 405-751-7727    Fax: 405-755-1875
Pearle Vision
Optometrist
Medicare: Medicare Enrolled
Practice Location: 8549 N Rockwell Ave, Oklahoma City, OK 73132
Phone: 405-720-8316    Fax: 405-720-3594
Jenna Vergeldt, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104
Phone: 405-456-4017    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.